CHICAGO, IL / ACCESS Newswire / July 9, 2025 / Dr. Anosh Ahmed, a respected Republican figure and founder of the Anosh Supports America First Foundation, has pledged immediate aid to families affected ...

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in ...

Design Sets a New 2025 Bar for Healthcare AI TAMPA, FL / ACCESS Newswire / July 8, 2025 / While healthcare AI adoption is frequently hindered by poor design, weak integration, and limited clinician ...

While more than 90% of Americans support organ donation, only 52% of North Carolina's licensed drivers are registered organ, ...

Gut Zoomer provides insights crucial in identifying the root causes of chronic disease and other conditions that impact longevity SANTA CLARA, CA / ACCESS Newswire / July 8, 2025 / Vibrant Wellness, a ...

PrimeVigilance, is significantly enhancing its service offerings with Oracle Argus. Delivering the full lifecycle of pharmacovigilance services, the CRO is leveraging Argus to provide its clients with ...

Modus Therapeutics Holding AB (publ) (“Modus”) today announces that patient enrollment in Part 1 of its ongoing Phase IIa study evaluating sevuparin for the treatment of patients with chronic kidney ...

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Hone Health At-Home Testosterone Test + Telemedicine TRTHone Health is on a mission to provide the best TRT services. It just announced it's taking its ...

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Eladynos® for the treatment of osteoporosis in postmenopausal women at very high risk of fracture*, through the NHS ...

Led Network Rooted in Clinical Excellence and Shared Values CHICAGO, IL / ACCESS Newswire / July 8, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists ...

Expanded offering delivers integrated radiopharmaceutical studies using clinically relevant isotopes and highly characterized PDX tumor models HACKENSACK, NJ / ACCESS Newswire / July 8, 2025 / ...

This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial ...